Harnessing resilience in patient treatment and long-term recovery: Psychosocial and neurobiological pathways to enhanced outcomes.

Resilience - the dynamic capacity to maintain or restore mental and physical health in the face of adversity - has been linked to improved treatment adherence, reduced psychological distress, and enhanced long-term recovery in patients confronting serious illnesses such as cancer. Psychosocial resources (e.g., social support, peer-led groups) and neurobiological mechanisms (e.g., Hypothalamic-Pituitary-Adrenal axis modulation, neural plasticity) interact to buffer the physiological and emotional impact of diagnosis and therapy. Interventions including cognitive-behavioural therapy, mindfulness-based stress reduction, and digitally delivered programs demonstrate moderate-to-large effect sizes (Hedges' g 0.33-1.45) in strengthening resilience and improving quality of life. However, inconsistent terminology, the absence of standardized, multidimensional assessment tools, and logistical challenges in implementation limit widespread adoption. We advocate for a unified resilience framework that integrates psychometric scales, biomarker assays, and real-time digital monitoring; the embedding of resilience-promoting strategies within multidisciplinary care pathways; and the alignment of policy support and reimbursement models to sustain these efforts. Longitudinal, multicenter trials and culturally sensitive adaptation will be essential to validate scalable models, ensuring that resilience becomes a fundamental pillar of compassionate, patient-centered care.